Brady W. Dougan, Director at Humacyte, Inc. (HUMA), sold 2,000,000 shares at $2.78 ($5.6M) on 2023-09-14, disclosed to the SEC on 2023-09-15.
Open-market sale of $5.6M HUMA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| HUMA | SELL | 2024-11-20 | $13.2M | — | Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |